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Abstract
Aims
Abdominal aortic aneurysm (AAA) is an age-associated disease characterized by chronic
inflammation, vascular cell apoptosis and metalloproteinase-mediated extracellular matrix deg-
radation. Despite considerable progress in identifying targets involved in these processes, ther-
apeutic approaches aiming to reduce aneurysm growth and rupture are still scarce.
Indoleamine 2–3 dioxygenase 1 (IDO) is the first and rate-limiting enzyme involved in the
conversion of tryptophan (Trp) into kynurenine (Kyn) pathway. In this study, we investigated
the role of IDO in two different models of AAA in mice.
Methods and results
Mice with deficiencies in both low density receptor-deficient (Ldlr-/-) and IDO (Ldlr-/-Ido1-/-)
were generated by cross-breeding Ido1-/- mice with Ldlr-/-mice. To induce aneurysm, these
mice were infused with angiotensin II (Ang II) (1000 ng/min/kg) and fed with high fat diet
(HFD) during 28 days. AAAs were present in almost all Ldlr-/- infused with AngII, but only in
50% of Ldlr-/-Ido1-/- mice. Immunohistochemistry at an early time point (day 7) revealed no
changes in macrophage and T lymphocyte infiltration within the vessel wall, but showed
reduced apoptosis, as assessed by TUNEL assay, and increased α-actin staining within the
media of Ldlr-/-Ido1-/- mice, suggesting enhanced survival of vascular smooth muscle cells
(VSMCs) in the absence of IDO. In another model of elastase-induced AAA in C57Bl/6
mice, IDO deficiency had no effect on aneurysm formation.
Conclusion
Our study showed that the knockout of IDO prevented VSMC apoptosis in AngII -treated
Ldlr-/- mice fed with HFD, suggesting a detrimental role of IDO in AAA formation and thus
would be an important target for the treatment of aneurysm.
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Introduction
Abdominal aortic aneurysm (AAA) is an age-associated disease with increasing incidence and
considerable consequences on morbidity and mortality [1]. Mechanistically, AAA is character-
ized by vessel dilatation due to medial degeneration with elastin degradation, collagen remod-
eling, vascular smooth muscle cell (VSMC) apoptosis and chronic aortic wall inflammation
[2]. Matrix remodeling is conditioned by the imbalance between metalloproteinases (MMP)
and Tissue Inhibitor of Metalloproteinases (TIMP) [3]. However, until now, open surgical
repair appears as the only accessible approach, as no therapeutic targets have been yet identi-
fied to prevent aneurysm growth or rupture.
Indoleamine 2 3- dioxygenase 1 (IDO) is an enzyme that catalyzes the degradation of the
essential amino acid L-tryptophan (Trp) to N-formylkynurenine leading to the generation of
several active metabolites constituting the kynurenine (Kyn) pathway [4]. Recently, experi-
mental studies showed that IDO was involved in the pathogenesis of atherosclerosis [5, 6], and
its plasma activity was associated with worse cardiovascular outcome in coronary patients [6–
9]. Angiotensin (Ang) II, widely used to induce dissecting aortic aneurysm [10], was previously
shown to increase IDO activity through the production of mitochondrial reactive oxygen spe-
cies [11]. Moreover, a recent report indicates that IDO deficiency in AngII-infused apolipo-
protein e-deficient (Apoe-/-) mice protects against AAA[12]. The authors attributed the pro-
aneurysmal effect of IDO to one of the Kyn-derived metabolites, 3-hydroxyanthranilic acid
(3-HAA), which induced aneurysm by increasing MMP-2 expression in VSMC[12].
High fat diet (HFD) containing cholesterol has been shown to accelerate AngII-induced
aneurysm formation in mice [13, 14], which mimics some aspects of aneurysmal human dis-
ease [15]. In this study, we investigate the role of IDO in two murine models of AAA using low
density receptor-deficient (Ldlr-/-) mice fed a HFD during 28 days, either after infusion of
AngII (dissecting AAA) or after topical peri-aortic elastase (non-dissecting AAA)
Materials and methods
Mice and aneurysm models
Experiments were conducted according to the guidelines formulated by the European Com-
munity for experimental animal use (Directive 2010/63/EU) and were approved by the Ethics
Committee of INSERM and the French Ministry of Agriculture (agreement A75-15-32). All
experiments were conducted on male mice between 8 and 12 weeks of age. C57Bl/6 Ido1-/- and
Ldlr-/- mice were from the Jackson Laboratory. Ldlr-/-Ido1-/- mice were obtained by crossing
Ido1-/- and Ldlr-/- mice.
AAA was induced in hypercholesterolemic mice as previously described in[10]. AAA was
induced in Ldlr-/- and Ldlr-/- Ido1-/- mice by subcutaneous infusion of AngII (Sigma-Aldrich)
at 1μg/kg/min and high fat diet (HFD) containing 15% fat, 1.25% cholesterol, and 0% cholate
for 7 days or 28 days. Angiotensin II (Ang II) was purchased from Sigma-Aldrich (St. Louis,
MO, USA), and ALZET osmotic pumps (model 2004) were from Charles River Laboratories.
A 5-point grading system was used to classify aneurysms based on Daugherty et al classifica-
tion [16]. Type 0: Normal aorta. Type I, dilated lumen in the supra-renal region of the aorta
with no thrombus. Type II, remodeled tissue in the supra-renal region that frequently contains
thrombus. Type III, a pronounced bulbous form of Type II that contains thrombus. Type IV, a
form in which there are multiple aneurysms containing thrombus, some overlapping, in the
suprarenal area of the aorta or rupture.
The second model of AAA was performed as previously reported[17]. Briefly, normocho-
lesterolemic C57Bl/6J and C57Bl/6 Ido1-/- were anesthetized with 2% Isoflurane, placed on a
IDO and aneurysm
PLOS ONE | https://doi.org/10.1371/journal.pone.0193737 March 1, 2018 2 / 12
heating pad and received 0.05 mg/kg subcutaneous (s.c.) buprenorphine. After median lapa-
rotomy, the abdominal aorta, from the left renal vein to the iliac bifurcation, was exposed and
bathed in 10 μL of filtered porcine pancreatic elastase (E1250; Sigma-Aldrich) during 5 min.
The aorta was flushed three times with 0.9% NaCl to stop reaction.
Characterization of aneurysmal lesions
The suprarenal region of the abdominal aorta containing AAAs was serially cross-sectioned
(8 μm sections). Paraffin embedded aortas were used for different stainings. Elastin staining
was visualized using Orcein, the mean number of elastin layers was quantified for each mice.
The extent of vascular smooth muscle cells (VSMC) was evaluated using anti-αSMC (Sigma-
Aldrich) within media. T lymphocytes were detected using anti-CD3 antibody (Dako), macro-
phages using anti-CD68 antibody (AbD serotec). IHC chromogen substrate AEC (Thermo sci-
entific) was used for revelation. The extent of apoptosis cells was evaluated by Terminal dUTP
nick end-labelling (TUNEL) staining, using In Situ Cell Death Detection Kit (Sigma-Aldrich).
We performed morphometric studies using Histolab software (Microvisions).
Flow cytometry
Flow cytometry staining was performed at day 7 after AngII infusion. Monocytes were identi-
fied as CD11b+CD115+, classical monocytes CD11b+CD115+GR-1high and nonclassical
monocytes CD11b+CD115+GR-1low. Stainings included the following antibodies: V-450 or
FITC-conjugated anti-CD11b (M1/70, BD Biosciences) PE-conjugated anti-CD115 (AFS 98,
eBioscience) Anti-Gr1 (Ly6C and G)-PERCP-Cy5 (RB6-8C5, BD Biosciences), anti-CD4-
V-450 (RM4-5, eBioscience) anti-CD3ε- APC (145-2C11, eBioscience), anti-CD8a-AF-700
(53–6.7, BD Biosciences) anti-MHCII- FITC (M5/114.15.2, eBioscience) anti-CD19-AF-700
(6D5, BD Biosciences) and APC-conjugated CD25 (PC61.5). Intracellular staining of forkhead
box P3 (PE or PECy 7-conjugated FOXP3) (eBiosciences) was performed. For intracellular
cytokine staining, splenocytes were stimulated in vitro for 4 h using leukocyte activation cock-
tail (BD) and with lipopolysaccharide (LPS) at 1 ug/ml for IL-10 staining. Briefly, cells were
stained for surface markers followed by fixation and permeabilization using a kit (eBios-
ciences) for intracellular staining. Then, cells were stained with Brilliant Violet 421-conjugated
Ifn-γ (clone XMG1.2), PE-conjugated Il-17 (clone TC11-18H10.1) (BioLegend) and APC-con-
jugated Il10 (clone JES5-16E3) (eBiosciences).
Forward scatter (FSC) and side scatter (SSC) were used to gate live cell excluding red blood
cells, debris, and cell aggregates in total blood cells and splenocytes. Cells were acquired using a
BD LSRII Fortessa flow cytometer (BD Biosciences) and analyzed with FlowJo (Tree Star, Inc.).
HPLC measurements
100 μL of the sample were deproteinized by 50 μl of 15% perchloric acid. The proteins were pel-
leted by centrifugation at 13,000 rpm for 30 minutes. Separation of Kyn and Trp was done by
reversed-phase liquid chromatography using a 20mM NaH2PO4 buffer (not pH adjusted) with
5.0% acetonitrile. The mobile phase was delivered by an HPLC pump (Shimadzu, Japan) through
a Supelcosil C18 column (250 mm x 4.6 mm, 5 μm, Supelco, USA) at a rate of 1 ml/min. Follow-
ing separation, the analysate was first passed through a guard cell with an oxidizing potential of 50
mV. Samples were then quantified by sequential oxidation and reduction in a high-sensitivity ana-
lytical cell (ESA 5010; ESA Inc, USA) controlled by a potentiostat (Coulochem III; ESA Inc, USA)
with an applied potential of 600 mV and 700 mV for detection of Kyn and Trp. The signals from
the detector were transferred to a computer for analysis (Labsolution, Shimadzu). The retention
time of Kyn was approximately 12 min and approximately 21 min for Trp.
IDO and aneurysm
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10–20 mg of aorte samples were lyzed and deproteinized by 150 μl of 7.5% perchloric acid.
Lysis was complete by the sonication and the proteins were pelleted by centrifugation at
13,000 rpm for 30 minutes. Separation of Kyn and Trp was done by reversed-phase liquid
chromatography using a 20mM NaH2PO4 buffer (not pH adjusted) with 5.0% acetonitrile.
The mobile phase was delivered by an HPLC pump (Shimadzu, Japan) through a Supelcosil
C18 column (250 mm x 4.6 mm, 5 μm, Supelco, USA) at a rate of 1 ml/min. Following separa-
tion, the analysate was first passed through a guard cell with an oxidizing potential of 50 mV.
Samples were then quantified by sequential oxidation and reduction in a high-sensitivity ana-
lytical cell (ESA 5010; ESA Inc, USA) controlled by a potentiostat (Coulochem III; ESA Inc,
USA) with an applied potential of 600 mV and 700 mV for detection of Kyn and Trp. The sig-
nals from the detector were transferred to a computer for analysis (Labsolution, Shimadzu).
The retention time of Kyn was approximately 13 min and approximately 17.5 min for Trp.
The sensitivity of the system was verified by analysis of standard mixtures of Kyn, with concen-
trations from 50 to 1000nM, and Trp, with concentrations from 0.5 to 50 μM, resulting in a
linear standard plot.
Quantitative real time polymerase chain reaction
The abdominal aorta was cleared of all the surrounding tissues. Tissue samples were pulverised
using IKA™ T 25 digital homogenizer (Thermo Fisher Scientific). Total RNA was extracted
from tissue samples using Trizol reagent (Invitrogen). Isolated RNA was reverse-transcribed
using Quantitect Reverse Transcription kit (Qiagen). Real-time PCR was performed on cDNA
product using Takyon qPCR mix on an Step-One Plus (Applied Biosystems) in duplicates.
GAPDH was used to normalize gene expression. The following primer sequences were used:
Gapdh (F: 50-CGT CCC GTA GAC AAA ATG GTG AA-30; R: 50-GCC GTG AGT
GGA GTC ATA CTG GAA CA-30);
TIMP-1 (F: 50-CCC CCT TTG CAT CTC TGG CAT CT-30; R: 50-GCG GTT CTG
GGA CTT GTG GGC ATA-30);
TIMP-2 (F: 50-GGC-CCC-CTC-TTC-AGG-AGT-30; R: 50-TCC-CAG-GGC-ACA-
ATG-AAG-T-30);
TIMP-3 (F: 50-GGC-CTC-AAT-TAC-CGC-TAC-CAC-30; R: 50-GGC-GTT-GCT-
GAT-GCT-TTC-GT-30);
MMP-2 (F: 50-CCG AGA CCG CTA TGT CCA CTG T-30; R: 50-CCG GTC ATC
ATC GTA GTT GGT TGT-30);
MMP-9 (F: 50-CCG TCA TTC GCG TGG ATA AGG AGT-30; R: 50-GTA GCC CAC
GTC CAC CTG GTT-30);
MMP-12 (F: 50-CCC CCA TCC TTG ACA AAA CCT-30; R: 50-TGG CGA AGT GGG
TCA AAGA-30). Relative expression was calculated using the 2-delta-delta CT method.
Ex vivo reflectance epifluorescence imaging
Mice were anaesthetized with isoflurane and received intravenously 150 μL of a fluorescent
imaging probe MMPsense 680 (NEV 10126, PerkinElmer) 24 h before sacrifice. This agent is
optically silent in its unactivated state and becomes highly fluorescent following activation by
Fig 1. IDO deficiency protects against AAA in AngII-induced aneurysm in Ldlr-/- mice fed a high fat diet. A-B Images and classification of aortic
aneurysm in Ldlr-/- (n = 10) and Ldlr-/-Ido1-/- (n = 10) mice infused with AngII (1000ng/min/kg) and fed a high fat diet (HFD) during 28 days. The
results were confirmed in two independent experiments (n = 10 per group). C-E Representative images and quantifications of apoptotic area assessed by
TUNEL assay (C), α-actin staining (D) and elastin layers visualized by Orcein coloration (E) in Ldlr-/- (n = 10) and Ldlr-/-Ido1-/- (n = 10) mice infused
with AngII (1000ng/min/kg) and fed HFD for 28 days. Mean values ± SEM are shown. P0.05.
https://doi.org/10.1371/journal.pone.0193737.g001
IDO and aneurysm
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MMPs including MMP-2, -3, -9, and -13. Images were acquired using a fluorescence molecular
imaging system (FMT 2500TM, VisEn Medical).
Statistics
Values are expressed as means ± s.e.m. Differences between values were examined using Mann
Whitney test and χ2 test for a trend. Values were considered significant at P0.05.
Results and discussion
IDO deficiency protects against AngII-induced AAA in Ldlr-/- mice fed a HFD
IDO is involved in the conversion of Trp to Kyn. We then examined the effects of HFD and
AngII on plasma Trp and Kyn in Ldlr-/- mice. As shown in S1 Fig, after 28 days of HFD alone,
no significant increase of Kyn was observed in the plasma of Ldlr-/- mice (P = 0.14). However,
in agreement with a previous study [11], AngII infusion (1000 ng/min/kg) significantly
increased plasma Kyn without Trp changes in Ldlr-/- mice after 1 week of treatment (P = 0.02),
suggesting that AngII stimulated IDO activity.
To study the role of IDO in aneurysm, we generated double knockout Ldlr-/-Ido1-/- mice,
and put Ldlr-/-Ido1+/+ and Ldlr-/-Ido1-/- mice on HFD with Ang II infusion (1000 ng/min/kg)
during 28 days.
IDO was previously shown to contribute to vessel relaxation in lipopolysaccharide-induced
endotoxin shock[18]. We thus determined systolic blood pressure levels in Ldlr-/-Ido1+/+ and
Ldlr-/-Ido1-/- mice subjected to AngII and HFD at day 0, 5, and 14. As expected, Ang II signifi-
cantly increased systolic blood pressure in Ldlr-/-Ido1+/+ mice, but the increase was similar in
Ldlr-/-Ido1-/- mice (S2 Fig), indicating that IDO was not involved in the regulation of systolic
blood pressure in our model. As depicted in Fig 1A and 1B, the absence of IDO protected
against AngII-induced aneurysm formation and severity (P<0.0001). This protective effect
was associated with significantly reduced TUNEL positive area (p = 0.05) (Fig 1C) and
increased α-actin staining (p = 0.03) (Fig 1D), as well as a trend towards more elastic layers
within the media (p = 0.07) (Fig 1E).
To investigate the mechanisms involved in AAA formation, we implanted Ldlr-/-Ido1+/+
and Ldlr-/-Ido1-/- mice with pumps infusing either PBS or Ang II, and then put the mice on
HFD for a short duration (7 days). Inflammation was previously shown to be involved in aneu-
rysm pathogenesis [19]. We thus examined whether changes in inflammatory responses may
account for our findings.
As shown in S3 Fig, we found no significant differences in circulating neutrophils, classical
and non-classical monocytes, CD4+ and CD8+ T cells, and CD19+ B cells in PBS-infused
Ldlr-/-Ido1+/+ compared to Ldlr-/-Ido1-/- mice fed with HFD. Production of spleen IFN-γ and
IL-10 was unchanged, but IL-17 production was increased in PBS-infused Ldlr-/-Ido1-/- com-
pared to Ldlr-/-Ido1+/+ mice (S3 Fig).
Of note, in AngII-infused Ldlr-/- group one mouse died before day 7 because of aneurysm
rupture. No significant differences were observed in circulating neutrophils, classical and
non-classical monocytes, CD4+, CD8+ T cells, CD8+, and CD19+ B cells in Ang II-infused
Ldlr-/-Ido1+/+ compared to Ldlr-/-Ido1-/- mice fed with HFD (S4 Fig). A significant decrease in
protective T regulatory cells [20] was observed in the spleens of AngII-infused Ldlr-/-Ido1-/-
Fig 2. IDO deficiency prevents AngII-induced vascular smooth muscle cell apoptosis. A-D Representative images and quantifications of macrophages
(CD68 staining) (A) T lymphocytes (CD3 staining) (B), apoptotic area as assessed by TUNEL assay (C) and α-actin (D) in Ldlr-/- infused either PBS
(n = 5), AngII (n = 5) and Ldlr-/-Ido1-/- mice infused with AngII (n = 5) for 7 days. Mean values ± SEM are shown. P0.05, P<0.001.
https://doi.org/10.1371/journal.pone.0193737.g002
IDO and aneurysm
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compared to Ldlr-/-Ido1+/+ mice (P = 0.002), despite a protection against aneurysm in absence
of IDO. However, no significant differences were detected in IL-17, IL-10 and interferon (IFN)-
γ production by splenic lymphocytes of the 2 groups of mice (S4 Fig). Aneurysm formation was
associated with an accumulation of macrophages and T lymphocytes within the adventitia and
the media, but no significant differences were observed between AngII-infused Ldlr-/-Ido1+/+
and Ldlr-/-Ido1-/- mice (Fig 2A and 2B). A recent study reported that IDO promoted aneurysm
formation through 3HAA production, which activated MMP2 expression[12]. Therefore, we
investigated MMP expression and activity in our model. As shown in S5 Fig, we found no dif-
ferences in mRNA expression of MMP-2, -9 and -12, and no differences in TIMP-1, -2, and -3
in the abdominal aorta isolated from AngII-infused Ldlr-/-Ido1+/+ compared to Ldlr-/-Ido1-/-
mice. Moreover, MMP protease activity in the aortic wall, quantified using ex vivo reflectance
epifluorescence imaging, was similar in AngII-infused Ldlr-/-Ido1+/+ and Ldlr-/-Ido1-/- mice,
indicating that IDO is unlikely to be involved in MMP expression or activity in this model (S5
Fig). Interestingly however, AngII-induced TUNEL positivity within the media of AngII-
infused Ldlr-/- mice was prevented in the absence of IDO (P = 0.04) (Fig 2C), suggesting a pro-
tection of VSMC against apoptosis. In agreement with this observation, increased α-actin stain-
ing was observed within the media of AngII-infused Ldlr-/-Ido1-/- compared to Ldlr-/- mice
(P = 0.03) (Fig 2D). In agreement with this result, IDO activity, through the generation of
3-hydroxykynurenine, has been shown to promote endothelial cell apoptosis in vitro [11].
IDO deficiency does not alter aneurysm formation after elastase
application
We also tested the impact of IDO in a non-dissecting model of AAA induced by local elastase
application. The latter directly degrades elastin, leading to VSMC apoptosis and inflammation
within the media [21]. This model induces aortic dilatation without the need for hypercholes-
terolemia. Elastase-induced AAA formation did not induce Kyn production in aorta and was
not affected by IDO deficiency nor were VSMC apoptosis (TUNEL-positive area), α-actin
staining (Fig 3), and infiltration of T lymphocytes and macrophages (data not shown).
Taken together, our results show that IDO deletion protects against AAA formation in
HFD-fed Ldlr-/- mice by preventing AngII-induced VSMC apoptosis, but had no effect in
AngII-independent elastase-induced AAA formation.
Supporting information
S1 Fig. AngII increases kynurenine in plasma of Ldlr-/- mice. A-B plasma tryptophan (Trp)
and Kynurenine (Kyn) in Ldlr-/- mice at baseline (n = 10), after 4 weeks of HFD (n = 10), 1
week after AngII infusion (n = 10) and Ldlr-/-Ido1-/- mice 1 week after AngII infusion (n = 5).
(PDF)
S2 Fig. IDO deficiency has no effects on systolic blood pressure. Systolic blood pressure in
Ldlr-/- (n = 10) and Ldlr-/-Ido1-/- (n = 10) mice fed with HFD at baseline, 5 days and 14 days
after AngII infusion.
(PDF)
S3 Fig. IDO deficiency effects in Ldlr-/- infused with PBS and fed with HFD. A quantita-
tive analysis of flow cytometry staining of blood neutrophils (CD11b+GR-1+), monocytes
Fig 3. IDO deficiency has no effects in elastase-induced aneurysm model. A Trp and Kyn levels in aorta of C57Bl/6 mice sham group or C57Bl/6 or Ido-1-/- mice
treated with elastase (n = 4/per group) at day 3. B-D classification of aortic aneurysm in C57Bl/6 (n = 10) and Ido1-/- mice (n = 10) treated with elastase (B), α-actin
staining (C) and TUNEL area (D) at day 3 after elastase treatment in C57Bl/6 (n = 10) and Ido1-/- mice (n = 10).
https://doi.org/10.1371/journal.pone.0193737.g003
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(CD11b+CD115+) and subsets, classical (GR1 high) and non classical (GR1 low) monocytes
(B), B lymphocytes (CD19+) (C), T lymphocytes (CD4+, CD8+) (D) and T regulatory cells
(CD25+Foxp3+) gated on CD4+ cells (E) in Ldlr-/- and Ldlr-/-Ido1-/- mice (n = 4/group)
infused with PBS and fed with HFD during 7 days. F quantitative analysis of flow cytometry-
based intracellular staining of interleukin (IL)-17, IL-10 and interferon (IFN)- γ gated on sple-
nocytes in the 2 groups of mice.
(PDF)
S4 Fig. IDO deficiency effects in Ldlr-/- infused with AngII and fed with HFD. A quantita-
tive analysis of flow cytometry staining of blood monocytes (CD11b+CD115+) and subsets,
classical (GR1 high) and non classical (GR1 low) monocytes, neutrophils (CD11b+GR-1+), T
lymphocytes (CD4+, CD8+) and B lymphocytes (CD19+) cells in Ldlr-/- mice infused with
either PBS (n = 5) or Ang II (n = 5) and Ldlr-/-Ido1-/- mice infused with AngII (n = 5) and fed
with HFD during 7 days. B representative pictures and quantifications of T regulatory cells
(CD25+Foxp3+) gated on CD4+ cells. C quantitative analysis of flow cytometry-based intra-
cellular staining of interleukin (IL)-17, IL-10 and interferon (IFN)-γ gated on splenocytes in
the 3 groups of mice.
(PDF)
S5 Fig. IDO deletion has no effects on MMP expression and activity. A MMP 2, 9 and 12
and TIMP1, 2, and 3 mRNA in aorta of Ldlr-/- mice infused with either PBS (n = 5) or AngII
(n = 5) and Ldlr-/- Ido-1-/- (n = 5) mice infused with Ang II and fed with HFD during 7 days. B
Quantification of matrix metalloproteinase (MMP)-sense 680 activity in the abdominal and
thoracic aorta, measured by ex vivo reflectance epifluorescence imaging in AngII-infused
Ldlr-/- and Ldlr-/- Ido1-/- mice (n = 5/group) fed with HFD during 7days.
(PDF)
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